Footnotes
This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.
Conflict of interest: The authors report no conflicts of interest in this work.
The author RRH reports receiving personal fees from GlaxoSmithKline and AstraZeneca for speaking engagements. ARV reports receiving personal fees from GlaxoSmithKline, AstraZeneca, and Boehringer Ingelheim for speaking engagements. RHZ reports receiving personal fees from GlaxoSmithKline and AstraZeneca for speaking engagements.
This is a PDF-only article. Please click on the PDF link above to read it.
- Received April 5, 2024.
- Accepted July 17, 2024.
- Copyright ©The authors 2024
This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions{at}ersnet.org
